000 | 01428 a2200397 4500 | ||
---|---|---|---|
005 | 20250513125156.0 | ||
264 | 0 | _c19971002 | |
008 | 199710s 0 0 eng d | ||
022 | _a0002-9343 | ||
024 | 7 |
_a10.1016/s0002-9343(97)90029-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeeman, E | |
245 | 0 | 0 |
_aOsteoporosis: trials and tribulations. _h[electronic resource] |
260 |
_bThe American journal of medicine _cAug 1997 |
||
300 |
_a74S-87S; discussion 87S-89S p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAlendronate _xtherapeutic use |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aCalcitonin _xtherapeutic use |
650 | 0 | 4 |
_aCalcium, Dietary _xtherapeutic use |
650 | 0 | 4 | _aEstrogen Replacement Therapy |
650 | 0 | 4 |
_aEtidronic Acid _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorides _xtherapeutic use |
650 | 0 | 4 |
_aFractures, Bone _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOsteoporosis _xcomplications |
650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdrug therapy |
650 | 0 | 4 |
_aParathyroid Hormone _xtherapeutic use |
650 | 0 | 4 |
_aVitamin D _xtherapeutic use |
773 | 0 |
_tThe American journal of medicine _gvol. 103 _gno. 2A _gp. 74S-87S; discussion 87S-89S |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9343(97)90029-2 _zAvailable from publisher's website |
999 |
_c9281217 _d9281217 |